Merkle launches healthcare practice

Share this article:
Database marketing agency Merkle has launched a healthcare practice, led by former GlaxoSmithKline director of integrated marketing Jeff Wiltrout.

The decision to formalize its healthcare practice, after several years of servicing various clients in the space, results from an increased focus on relationship marketing, according to Wiltrout. Managing relationships with consumers—or patients— requires a technology-enabled and intelligence-based strategy, something pharma has been slow to implement out of the gate. 

“Companies like Geico, Direct TV and Dell rely heavily on data-driven, direct customer relationships—they turned to that several years ago,” said Wiltrout. Pharma has made inroads in these areas, especially in compliance and persistency, but “they haven't completely embraced it yet,” he said. Pharma needs to move from being brand-centric to customer-centric, from a strategic perspective, said Wiltrout. Companies have to start using data to drive analytics, in order to more efficiently “find out who the customers are, and what kinds of services they need,” he said. 

Merkle's healthcare practice will pool resources from many aspects of the company, which is headquartered in Columbia, Maryland. Merkle also has offices in Denver, Seattle, Boston, Chicago and elsewhere. According to Wiltrout, a large client engagement would probably get 12 to 15 dedicated account people assigned to the work. Capabilities include media mix optimization, ROI measurement, direct marketing, interactive and others, spanning professional and consumer marketing. 

According to a company spokesperson, Merkle's business is roughly 60% strategy, analytics and technology, with 40% of its resources devoted to more traditional agency services. Merkle's clients include GSK and Sanofi-Aventis, among other pharma and healthcare-related accounts, according to a company statement. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?